Since the molecular pathogenesis of leukemia subtypes can be different, the expression of Beclin 1 and LC3 genes in larger study groups should be analyzed to determine the relationship between gene expression levels and leukemia subtypes. In addition, the levels of gene expression in different stages of leukemia and its relationship with the type of treatment should be investigated. This evidence concerns the gene BECN1 and leukemia.